Definitive Healthcare Toekomstige groei
Future criteriumcontroles 0/6
Definitive Healthcare is forecast to grow earnings and revenue by 97.7% and 0.8% per annum respectively. EPS is expected to grow by 96.1% per annum. Return on equity is forecast to be 7.9% in 3 years.
Belangrijke informatie
97.7%
Groei van de winst
96.1%
Groei van de winst per aandeel
| Healthcare Services winstgroei | 30.6% |
| Inkomstengroei | 0.8% |
| Toekomstig rendement op eigen vermogen | 7.9% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 04 Oct 2024 |
Recente toekomstige groei-updates
Recent updates
Definitive Healthcare: Poor Near-Term Outlook, But New CEO May Change Things
Aug 19More Unpleasant Surprises Could Be In Store For Definitive Healthcare Corp.'s (NASDAQ:DH) Shares After Tumbling 28%
Aug 01
Definitive Healthcare: Weak Near-Term Growth To Put Valuation In Rangebound
Jun 25Risks Still Elevated At These Prices As Definitive Healthcare Corp. (NASDAQ:DH) Shares Dive 26%
May 30Pinning Down Definitive Healthcare Corp.'s (NASDAQ:DH) P/S Is Difficult Right Now
Apr 14Definitive Healthcare: Reiterate Buy Rating As I Expect Growth To Recover In FY25
Mar 19Is Definitive Healthcare (NASDAQ:DH) Using Debt In A Risky Way?
Feb 16An Intrinsic Calculation For Definitive Healthcare Corp. (NASDAQ:DH) Suggests It's 42% Undervalued
Dec 29Definitive Healthcare Corp. (NASDAQ:DH) Stock Rockets 31% As Investors Are Less Pessimistic Than Expected
Nov 24Estimating The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)
Jun 02Definitive Healthcare Corp. (NASDAQ:DH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 06A Look At The Fair Value Of Definitive Healthcare Corp. (NASDAQ:DH)
Dec 08Definitive Healthcare Grows Headcount Despite Gathering Recession Clouds
Aug 31Definitive Healthcare Corp.'s (NASDAQ:DH) Intrinsic Value Is Potentially 27% Above Its Share Price
Jul 17Definitive Healthcare: No Involvement Yet Here
Jun 05Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 263 | -28 | 120 | 100 | 6 |
| 12/31/2025 | 254 | -24 | 82 | 82 | 11 |
| 12/31/2024 | 249 | -288 | 72 | 72 | 12 |
| 6/30/2024 | 258 | -405 | 43 | 45 | N/A |
| 3/31/2024 | 256 | -200 | 41 | 43 | N/A |
| 12/31/2023 | 251 | -202 | 38 | 41 | N/A |
| 9/30/2023 | 246 | -182 | 25 | 32 | N/A |
| 6/30/2023 | 238 | -14 | 25 | 33 | N/A |
| 3/31/2023 | 232 | -11 | 28 | 37 | N/A |
| 12/31/2022 | 223 | -7 | 27 | 36 | N/A |
| 9/30/2022 | 208 | -27 | 39 | 44 | N/A |
| 6/30/2022 | 194 | -32 | 29 | 32 | N/A |
| 3/31/2022 | 179 | -16 | 22 | 25 | N/A |
| 12/31/2021 | 166 | -18 | 18 | 25 | N/A |
| 9/30/2021 | 153 | -8 | 24 | 30 | N/A |
| 6/30/2021 | 140 | N/A | 26 | 31 | N/A |
| 3/31/2021 | 128 | 2 | 25 | 30 | N/A |
| 12/31/2020 | 118 | N/A | 22 | 23 | N/A |
| 12/31/2019 | 86 | -36 | 20 | 22 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: DH is forecast to remain unprofitable over the next 3 years.
Winst versus markt: DH is forecast to remain unprofitable over the next 3 years.
Hoge groeiwinsten: DH is forecast to remain unprofitable over the next 3 years.
Omzet versus markt: DH's revenue (0.8% per year) is forecast to grow slower than the US market (8.9% per year).
Hoge groei-inkomsten: DH's revenue (0.8% per year) is forecast to grow slower than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: DH's Return on Equity is forecast to be low in 3 years time (7.9%).